Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,528.00
Bid: 12,526.00
Ask: 12,530.00
Change: -62.00 (-0.49%)
Spread: 4.00 (0.032%)
Open: 12,626.00
High: 12,646.00
Low: 12,496.00
Prev. Close: 12,590.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-European stocks slammed by lockdown fears, end six-week rally

Fri, 19th Nov 2021 10:34

* Austria reimposes full lockdown

* Lagarde reaffirms dovish stance

* Hermes soars again index inclusion talk
(Adds comments, updates prices throughout)

By Anisha Sircar and Shreyashi Sanyal

Nov 19 (Reuters) - European stocks ended in the red on
Friday, clocking their first weekly decline in seven weeks on
concerns over the economic damage from fresh COVID-19 lockdowns
in the region that hammered cyclical sectors such as banks and
automakers.

The pan-European STOXX 600 index fell 0.3% after
hovering near record highs earlier in the session. The index
ended the week 0.1% lower.

It lost ground after news that Austria will become the first
country in western Europe to reimpose a full COVID-19 lockdown
this autumn to tackle a new wave of infections.

Germany's Health Minister Jens Spahn said the coronavirus
situation in the country was so grave that a lockdown, including
for people who have been vaccinated, cannot be ruled out.

"Any thoughts that the vaccines would offer a way to a more
normal Christmas period appear to have gone up in smoke for now,
in Europe at least, although there is a nagging fear this could
ripple out across the region," said Michael Hewson, chief market
analyst at CMC Markets.

Frankfurt shares fell 0.4%, while sectors more
exposed to economic cycles such as banks, automakers
and travel & leisure fell between 1.5% and 2.2%.

South European markets, including those in Spain and
Italy, fell about 1.5% each.

European stocks have hit a series of record highs this month
as a stronger-than-expected earnings season helped investors
look past concerns about rising inflationary pressures.

European Central Bank President Christine Lagarde said
inflation in the euro zone will fade so the ECB should not
tighten policy as it could choke off the recovery, and hinted at
continued bond purchases next year.

The ECB is due to decide on the future of its bond-purchase
programmes at its Dec. 16 policy meeting.

Irish airline Ryanair dropped 2.3% after announcing
its intention to delist from the London Stock Exchange,
citing costs related to retaining an additional listing.

French luxury group Hermes gained 5.2%, after
jumping more than 6% in the previous session, on market talks
that it may be added to the Eurostoxx 50 index during a December
review.
(Reporting by Anisha Sircar, Shreyashi Sanyal and Sruthi
Shankar in Bengaluru; Editing by Shounak Dasgupta,Aditya Soni
and Marguerita Choy)

More News
21 May 2024 17:04

LONDON MARKET CLOSE: London dips as eyes turn to UK inflation reading

(Alliance News) - Stock prices in London closed in the red on Tuesday, as investors nervously eye a key UK inflation reading, which could prompt the Bank of England to consider interest rate cuts.

Read more
21 May 2024 15:00

London close: Stocks fall ahead of key inflation reading

(Sharecast News) - London stocks ended in negative territory on Tuesday, influenced by the latest UK economic outlook from the International Monetary Fund (IMF) and comments from US Federal Reserve officials.

Read more
21 May 2024 12:03

CORRECT: Stocks fall but pound up as IMF ups UK forecast

(Correcting London Stock Exchange index prices.)

Read more
21 May 2024 12:00

LONDON MARKET MIDDAY: Stocks fall but pound up as IMF ups UK forecast

(Alliance News) - Stock prices in Europe were lower heading into Tuesday afternoon, with shares in New York also set for a muted open, as a recent rally for equities takes a pause.

Read more
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030

*

Read more
21 May 2024 09:04

LONDON MARKET OPEN: FTSE 100 declines after Asian stocks fall

(Alliance News) - Stock prices in London opened in the red on Tuesday, with some US interest rate cut optimism cooling after hawkish words from Federal Reserve central bankers.

Read more
21 May 2024 08:18

TOP NEWS: AstraZeneca eyes new era of growth with bold new revenue aim

(Alliance News) - AstraZeneca PLC on Tuesday set out its ambition to achieve USD80 billion in annual revenue by the end of the decade as it signalled a new "era of growth."

Read more
21 May 2024 07:52

LONDON BRIEFING: AstraZeneca plots "new era of growth"; SSP confident

(Alliance News) - London's FTSE 100 is called to open lower on Tuesday, following a mixed close in New York overnight, and tepid trade in Asia.

Read more
21 May 2024 07:34

AstraZeneca lays out plans to hit $80bn in revenues by 2030

(Sharecast News) - AstraZeneca has unveiled medium-term growth targets to nearly double group revenues by the end of the decade as it predicts significant growth from existing oncology, biopharmaceuticals and rare disease portfolios.

Read more
20 May 2024 11:55

LONDON MARKET MIDDAY: Gold shines amid interest rate cut hopes

(Alliance News) - Stock prices in London got a boost at midday on Monday, as investors eye a key UK inflation reading later in the week, which is expected to show cooling prices.

Read more
20 May 2024 08:56

AstraZeneca to build $1.5-bln cancer drug plant in Singapore

Plans to build ADCs manufacturing facility in Singapore

*

Read more
20 May 2024 08:24

TOP NEWS: AstraZeneca plans to build manufacturing plant in Singapore

(Alliance News) - AstraZeneca PLC on Monday announced plans for a USD1.5 billion manufacturing facility in Singapore to produce antibody drug conjugates, treatments that deliver "highly potent cancer-killing agents".

Read more
20 May 2024 07:47

LONDON BRIEFING: Keywords would back GBP2.0 billion bid as EQT circles

(Alliance News) - London's FTSE 100 is called to open higher at the start of the week, while the pound climbed and gold hit another record high, with investors hopeful the Federal Reserve could soon cut US interest rates.

Read more
20 May 2024 07:22

AstraZeneca announces $1.5bn Singapore manufacturing facility

(Sharecast News) - AstraZeneca announced plans to construct a $1.5bn manufacturing facility in Singapore on Monday, dedicated to the production of antibody drug conjugates (ADCs).

Read more
17 May 2024 22:25

Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial

May 17 (Reuters) - AstraZeneca owes Pfizer $107.5 million in damages, a Delaware federal jury said on Friday after finding that AstraZeneca's blockbuster lung cancer drug Tagrisso violated its Wyeth unit's patent rights.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.